BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Prognosis
17 results:

  • 1. A Nomogram for Predicting Progression-free Survival in Patients with Endometrial cancer.
    Wang Z; Zhao Z; Li W; Bao X; Liu T; Yang X
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e516-e527. PubMed ID: 37230875
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
    Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
    J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Using Immunohistochemical Markers and Clinicopathological Factors to Predict the Prognostic Survival of Different Types of Endometrial cancer Recurrence].
    Huang Z; Jiang P; Jia MZ; Li L; Deng Y; Lai L; Hu ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):489-496. PubMed ID: 34018370
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
    Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
    Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer.
    Wang X; Chen J; Sun W; Zhu M; Li D; Chen G
    J BUON; 2020; 25(2):757-763. PubMed ID: 32521864
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Outcomes in Early Cervical cancer Patients Treated with Nerve Plane-sparing Laparoscopic Radical Hysterectomy.
    Zhao D; Li B; Wang Y; Liu S; Zhang Y; Yuan G
    J Minim Invasive Gynecol; 2020; 27(3):687-696. PubMed ID: 31075445
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Role of
    Albano D; Zizioli V; Treglia G; Odicino F; Giubbini R; Bertagna F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):10-16. PubMed ID: 30396849
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Use of Functional Magnetic Resonance Imaging in Cervical cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
    Kalash R; Glaser SM; Rangaswamy B; Horne ZD; Kim H; Houser C; Beriwal S
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1008-1013. PubMed ID: 29559287
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Jeske YW; Ali S; Byron SA; Gao F; Mannel RS; Ghebre RG; DiSilvestro PA; Lele SB; Pearl ML; Schmidt AP; Lankes HA; Ramirez NC; Rasty G; Powell M; Goodfellow PJ; Pollock PM
    Gynecol Oncol; 2017 May; 145(2):366-373. PubMed ID: 28314589
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Primary intravascular large B cell lymphoma of the endometrium.
    Xia Y; Wang Y; Jiang Y; Yu W; Li Y; Xiang F; Wang C
    Acta Histochem; 2014 Jun; 116(5):993-6. PubMed ID: 24418320
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
    Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
    Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intravascular large B-cell lymphoma of the uterus: a case with favorable clinical outcome.
    Yamamoto T; Morita K; Iriyama N; Wakui K; Hiroi A; Sawada T; Masuda A; Kobayashi M
    Int J Surg Pathol; 2011 Oct; 19(5):672-6. PubMed ID: 19948641
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Lymphoepithelioma-like carcinoma of the uterine cervix.
    Takai N; Nakamura S; Goto K; Hayashita C; Kira N; Urabe S; Narahara H; Matsumoto H
    Arch Gynecol Obstet; 2009 Nov; 280(5):725-7. PubMed ID: 19238413
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix.
    Lenner P; Dillner J; Wiklund F; Hallmans G; Stendahl U
    Cancer Immunol Immunother; 1995 Mar; 40(3):201-5. PubMed ID: 7728779
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Studies on serum protein fractions of patients with uterine cervical cancer undergoing radiotherapy: relationship between changes in serum protein fractions and prognosis].
    Onizuka K; Migita S; Yamada H; Uwada O; Umemura Y; Kuroki M; Tateyama H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):1007-17. PubMed ID: 7971179
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A study of humoral factors in carcinoma cervix.
    Agarwal J; Gupta SC; Singh PA; Bisht D; Keswani NK
    Indian J Pathol Microbiol; 1992 Jan; 35(1):5-10. PubMed ID: 1452247
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.